During the past decade, HYKS Keuhkosairauksien tutkimusyksikkö conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HYKS Keuhkosairauksien tutkimusyksikkö" are "Idiopathic Pulmonary Fibrosis" (4 trials), "Pulmonary Disease, Chronic Obstructive" (2 trials), "Lung Diseases, Interstitial" (1 trials), "Pulmonary Emphysema" (1 trials) and "Scleroderma, Systemic" (1 trials). Many other conditions were trialed in "HYKS Keuhkosairauksien tutkimusyksikkö" in a lesser frequency.

Most popular intervention types in "HYKS Keuhkosairauksien tutkimusyksikkö" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Nintedanib" (3 trials), "BI 1015550" (2 trials), "FDC of tiotropium + olodaterol" (1 trials) and "Olodaterol" (1 trials). Other intervention names were less common.

The vast majority of trials in "HYKS Keuhkosairauksien tutkimusyksikkö" are 8 trials for "All" genders.

Currently, there are NaN active trials in "HYKS Keuhkosairauksien tutkimusyksikkö". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in HYKS Keuhkosairauksien tutkimusyksikkö, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HYKS Keuhkosairauksien tutkimusyksikkö, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".